(Q35145549)

6 August 2017

1 reference

title

Haemostasis in normal and abnormal pregnancy (English)

1 reference

6 August 2017

Máiread N O'Riordan

1

1 reference

PubMed ID

12787533

6 August 2017

John R Higgins

series ordinal

2

1 reference

PubMed ID

12787533

6 August 2017

language of work or name

1 reference

1 June 2003

1 reference

Best Practice & Research: Clinical Obstetrics & Gynaecology

6 August 2017

1 reference

6 August 2017

17

1 reference

6 August 2017

385-396

1 reference

6 August 2017

3

1 reference

The coagulation factor VII in pregnancy

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Changes in factor XI (plasma thromboplastin antecedent) levels during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Fibrinolytic enzyme system and pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Fibrinogen turnover in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Activated protein C resistance caused by Arg506Gln mutation in factor Va

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

The phenomenon known as acquired activated protein C resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Acquired activated protein-C resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Fibrinolysis in normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Fibrinolysis and plasminogen levels in pregnancy and the puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

A comparative study of blood fibrinolytic activity in normal women, pregnant women and women on oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Plasminogen activators and inhibitors in normal late pregnancy, postpartum and in the postnatal period

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

TAFI antigen and D-dimer levels during normal pregnancy and at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Hemostatic abnormalities may predict chronic hypertension after preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Early Doppler ultrasound screening in prediction of hypertensive disorders of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

On the pathogenesis of placental infarcts in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Establishing reference ranges of cord blood: point-of-care hemostatic function assessment in preterm and term neonates

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Source of increased plasminogen activators during pregnancy and puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Haemostatic Mechanism in the Uterine Circulation during Placental Separation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

The coagulation system during caerean section. Coagulation, fibrinolysis and hormonal levels in peripheral and uterine venous blood during caesarean section

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Changes in the fibrinolytic system during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Frequency of factor V(Leiden) and prothrombin G20210A in placentas and their relationship with placental lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900019-1

7 January 2021

10.1016/S1521-6934(03)00019-1

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12787533